Please be advised that Cytox Limited was placed into Liquidation on 4 January 2024, with Simon Farr and Anthony Collier of FRP Advisory Trading Limited being appointed Joint Liquidators of the Company. If you are owed money by Cytox Limited, or require further information about the Liquidation, please do not hesitate to contact email@example.com.
Mar 7, 2018
Cytox congratulates Professor John Hardy and his fellow winners of this year’s €1m Brain Prize
Cytox congratulates the four winners of the €1 million Brain Prize, ‘the Nobel of Neuroscience’, which was split between four biologists whose research has pinned down the origins and vulnerabilities of the disease.
Michel Goedert, Head of Neurobiology at Cambridge University’s Laboratory of Molecular Biology, Bart De Strooper, Director of the UK Dementia Research Institute at University College London, John Hardy, UCL Institute of Neurology London and Christian Haass, of Ludwig-Maximilians University in Munich, Germany all shared this year’s €1m Brain Prize for pivotal work that has changed our understanding of Alzheimer’s disease.
Dr Richard Pither, CEO of Cytox commented, “John Hardy is a much-valued member of our Scientific Advisory Panel, and he and his team at the UCL Institute of Neurology have played an important role in our research which has enabled Cytox to develop our groundbreaking comprehensive single nucleotide polymorphism profiling assay together with the use of polygenic risk scoring algorithms for Alzheimer’s disease risk stratification.”